Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

AIM: To assess the efficacy and tolerance of programmed death-1 (PD-1) and PD-ligand 1 (PD-L1) inhibitors and the impact of a standardised management-based protocol in a real-world setting. PATIENTS AND METHODS: Data from patients who had received anti-PD-(L)1 were collected from our pharmacy databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimaud, Fabien, Penaranda, Guillaume, Stavris, Chloé, Retornaz, Frédérique, Brunel, Véronique, Cailleres, Sylvie, Pegliasco, Hervé, Le Treut, Jacques, Grisoni, Vincent, Coquet, Emilie, Chiche, Laurent, Rognon, Amélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256379/
https://www.ncbi.nlm.nih.gov/pubmed/34234443
http://dx.doi.org/10.2147/TCRM.S308194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256379/
https://www.ncbi.nlm.nih.gov/pubmed/34234443
http://dx.doi.org/10.2147/TCRM.S308194

Ejemplares similares